# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-23-026701
Filing Date
2023-02-28
Accepted
2023-02-28 16:06:00
Documents
88
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | cldx-20221231x10k.htm iXBRL | 10-K | 2255127
2 | EXHIBIT 4.3 | cldx-20221231xex4d3.htm | EX-4.3 | 13416
3 | EXHIBIT 21.1 | cldx-20221231xex21d1.htm | EX-21.1 | 6018
4 | EXHIBIT 23.1 | cldx-20221231xex23d1.htm | EX-23.1 | 4934
5 | EXHIBIT 31.1 | cldx-20221231xex31d1.htm | EX-31.1 | 12461
6 | EXHIBIT 31.2 | cldx-20221231xex31d2.htm | EX-31.2 | 12287
7 | EXHIBIT 32 | cldx-20221231xex32.htm | EX-32 | 10278
13 | GRAPHIC | cldx-20221231x10k002.jpg | GRAPHIC | 57851
| Complete submission text file | 0001104659-23-026701.txt |  | 8466247

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20221231.xsd | EX-101.SCH | 51980
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20221231_cal.xml | EX-101.CAL | 67727
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20221231_def.xml | EX-101.DEF | 215036
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20221231_lab.xml | EX-101.LAB | 533111
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20221231_pre.xml | EX-101.PRE | 390826
82 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20221231x10k_htm.xml | XML | 1307682

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 23685135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances